0001171843-24-001307.txt : 20240312
0001171843-24-001307.hdr.sgml : 20240312
20240312200444
ACCESSION NUMBER: 0001171843-24-001307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blanchard Cheryl R
CENTRAL INDEX KEY: 0001326530
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 24744162
MAIL ADDRESS:
STREET 1: C/O ZIMMER, INC.
STREET 2: P.O. BOX 708
CITY: WARSAW
STATE: IN
ZIP: 46580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0508
4
2024-03-11
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001326530
Blanchard Cheryl R
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
1
0
0
President, CEO, Director
0
Common Stock
2024-03-11
4
M
0
14420
0
A
129614
D
Common Stock
2024-03-11
4
F
0
6973
25.42
D
122641
D
Common Stock
2024-03-11
4
M
0
20001
0
A
142642
D
Common Stock
2024-03-11
4
F
0
6473
25.42
D
136169
D
Common Stock
2024-03-11
4
M
0
30059
0
A
166228
D
Common Stock
2024-03-11
4
F
0
14534
25.79
D
151694
D
Common Stock
11742
I
Revocable Trust
Restricted Stock Unit
0.00
2024-03-11
4
M
0
14420
0
D
Common Stock
14420
0
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
20001
0
D
Common Stock
20001
40003
D
Restricted Stock Unit
0.00
2024-03-11
4
M
0
30059
0
D
Common Stock
30059
30060
D
Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 152 shares purchased on May 12, 2023 and 787 shares purchased on November 14, 2023.
Reflects an aggregate of 6,973 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
Reflects the first vesting installment of RSUs granted on March 9, 2023.
Reflects an aggregate of 6,473 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
Reflects the second vesting installment of RSUs granted on March 11, 2022.
Reflects an aggregate of 14,534 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.
/s/ Cheryl R. Blanchard
2024-03-12